Form 20-F Sanofi For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260217/A8Z7B22CO222P92Z2M2H2ZZ2BNDEZ22IZ282
Filed on: February 17, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
- Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
- Why does Barclays say it’s time to buy this Spanish stock?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
